Amaya gets price target cut at Cantor Fitzgerald

Anticipation of a weaker than expected third quarter has Cantor Fitzgerald Canada analyst Ralph Garcea feeling a little less bullish about Amaya (Amaya Stock Quote, Chart, News: TSX:AYA).

On Friday, Amaya reported its Q2, 2016 results. The company earned (U.S.) $22.49-million on revenue of $285.93-million, a topline that was up 10.2 per cent over the same period last year.

“We continue to execute on our 2016 strategy,” said Rafi Ashkenazi, whom Amaya also announced has become its permanent CEO. “Through focused expense management and product improvements and diversification, we delivered second quarter results that overcame seasonal headwinds and continued currency challenges, evidencing the strength of our combined core business. In addition, the special committee continues to focus on the strategic alternatives process with a committed view towards maximizing shareholder value.”

Garcea says Amaya’s second quarter was essentially in-line with his and the street’s expectations, but notes that headwinds are forming for the company’s next quarter.

“The company provided a July business update, that points to a weaker than expected Q3/16, explains the analyst. “Seasonally, Q3 is the weakest qtr as last year we saw Q3/Q2 down 3.7%; with Q4/Q3 up 17.6%.”

In a research update to clients today, Garcea maintained his “Buy” rating on Amaya but lowered his one-year target price on the stock from (C) $45.00 to (C) $40.00 (U.S target pice lowered from $34.00 to $30.80), implying a return of 89 per cent at the time of publication.

Garcea thinks Amaya will post Adjusted EBITDA of $496.3-million on revenue of $1.156-billion in fiscal 2016, numbers he expects wil climb to Adjusted EBITDA of $575.7-million on revenue of $1.338-billion the following year.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

13 hours ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

14 hours ago

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

2 days ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

2 days ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

2 days ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

4 days ago